![](/f/f/edb99351d8b637542eaefa34ca48e89b.jpg)
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2020
vol. 95 abstract:
Case report
Association of Budd-Chiari syndrome, essential thrombocytosis, and celiac disease
Agnieszka Bakula
1
,
Pawel Laguna
2
,
Joanna Cielecka-Kuszyk
3
,
Andrzej Kosciesza
4
,
Michal Brzewski
5
,
Piotr Socha
1
Pediatr Pol 2020; 95 (3): 191–195
Online publish date: 2020/10/30
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Herein we report the case of a girl with association of Budd-Chiari syndrome (BCS), essential thrombocythaemia (ET), and celiac disease (CD). To our knowledge, this is one out of eight cases in the literature of BCS complicated with CD, and the only one complicated with ET. This case is particularly significant because anagrelide therapy was started at an unusually early age. A four-year-old girl with ET treated with anagrelide was admitted to our hospital with suspicion of BCS. Ultrasound colour Doppler and computed tomography imaging revealed enlargement of the caudate lobe, splenomegaly, accessory hepatic veins, umbilical vein recanalisation, and ascites. The diagnosis of the CD was confirmed by serology (EmA IgA 1 : 800, tTG IgA > 130 U/ml). Two years later Duhring’s disease was confirmed histologically with recovery after diet modification. Four years later she is still being treated with anagrelide, anticoagulant drugs and is on a well-controlled gluten-free diet.
keywords:
children, celiac disease, Budd-Chiari syndrome, essential thrombocythaemia |